comparison of the age effect on the side effects of extubation during the use of lidocaine

comparison of the side effects of extubation during the use of intravenous lidocaine in higher and lower 50 years old people who candidate of internal laparoscopic cholecystectomy surgery.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230227057548N1

Enrollment

122

Registered

2023-05-15

Start date

2023-03-16

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In people undergoing internal laparoscopic cholecystectomy surgery.

Interventions

Intervention group: people undergoing internal laparoscopic cholecystectomy surgery, in this study, after obtaining informed consent from the patient's companion and after the completion of the surger

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Being at least 18 years old candidate of internal laparoscopic cholecystectomy surgery consent to participate in the study

Exclusion criteria

Exclusion criteria: pregnancy heart disease liver failure history of cardiopulmonary resuscitation history of respiratory disease high blood pressure mental retardation sensitivity to lidocaine psychological illness Kidney failure

Design outcomes

Primary

Measure	Time frame
In this study, the primary outcome is the incidence of laryngospasm, which is determined and charted by the capnograph tool. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: Side stream capnograph is used to measure laryngospasm.;The incidence of bronchospasm is determined and charted by the capnograph tool. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: side stream capnograph is used to measure bronchospasm.;The amount of sore throat that will be used through the Visual Analogue Scale. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: The Visual Analogue Scale for measuring pain represents a 10 cm line printed on a piece of paper with markers at each end indicating "no pain" at one end and "worst pain" at the other end or It is "indescribable pain".;The number of coughs counted and charted by the researcher. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: The number of coughs is counted by the researcher and recorded and charted in three ranges: low, medium, and high.	—

Measure

Time frame

In this study, the primary outcome is the incidence of laryngospasm, which is determined and charted by the capnograph tool. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: Side stream capnograph is used to measure laryngospasm.;The incidence of bronchospasm is determined and charted by the capnograph tool. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: side stream capnograph is used to measure bronchospasm.;The amount of sore throat that will be used through the Visual Analogue Scale. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: The Visual Analogue Scale for measuring pain represents a 10 cm line printed on a piece of paper with markers at each end indicating "no pain" at one end and "worst pain" at the other end or It is "indescribable pain".;The number of coughs counted and charted by the researcher. Timepoint: Immediately after extubation until exit from recovery for each patient in the study. Method of measurement: The number of coughs is counted by the researcher and recorded and charted in three ranges: low, medium, and high.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohammad mohammadifard

Ilam University of Medical Sciences

mmohammadifard2001@gmail.com+98 84 3337 5525

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026